1. | 3M Pharmaceuticals (1 study) |
2. | Abbott Laboratories (57 studies) |
3. | Abgenix (5 studies) |
4. | ACADIA Pharmaceuticals Inc. (1 study) |
5. | Acambis (4 studies) |
6. | Achillion Pharmaceuticals (4 studies) |
7. | Acorda Therapeutics (2 studies) |
8. | Actelion (5 studies) |
9. | Active Biotech Research (1 study) |
10. | Adams Laboratories (1 study) |
11. | Aderis Pharmaceuticals (1 study) |
12. | Advanced Bionics (1 study) |
13. | Advanced Biotherapy, Inc. (1 study) |
14. | Advanced Peptides (1 study) |
15. | Adventrx Pharmaceuticals (1 study) |
16. | Aeris Therapeutics (1 study) |
17. | Aeterna Laboratories (2 studies) |
18. | Agouron Pharmaceuticals (19 studies) |
19. | AJI Pharma USA (3 studies) |
20. | Alcon Research (21 studies) |
21. | Alexion Pharmaceuticals (3 studies) |
22. | Alfacell (1 study) |
23. | Alkermes (1 study) |
24. | Allergan (2 studies) |
25. | Allos Therapeutics (4 studies) |
26. | ALTANA Pharma (5 studies) |
27. | AltaRex (2 studies) |
28. | Alteon Inc. (4 studies) |
29. | ALZA (2 studies) |
30. | American Bioscience (7 studies) |
31. | American Medical Systems (1 study) |
32. | Amgen (51 studies) |
33. | Amylin Pharmaceuticals (12 studies) |
34. | Anderson Clinical Research (5 studies) |
35. | Andrulis Pharmaceuticals (1 study) |
36. | AnGes (1 study) |
37. | Angiotech Pharmaceuticals (1 study) |
38. | Anosys (1 study) |
39. | Anthra Pharmaceuticals (2 studies) |
40. | Antigenics (5 studies) |
41. | Apex Bioscience (1 study) |
42. | Aphton (2 studies) |
43. | Apollon (1 study) |
44. | Applied Genetics (1 study) |
45. | Applied Immunesciences (1 study) |
46. | Argus Pharmaceuticals (3 studies) |
47. | Ariad Pharmaceuticals (5 studies) |
48. | Aronex Pharmaceuticals (6 studies) |
49. | ArQule (1 study) |
50. | Array BioPharma (1 study) |
51. | Astra USA (10 studies) |
52. | AstraZeneca (41 studies) |
53. | AtheroGenics (1 study) |
54. | Avanir Pharmaceuticals (3 studies) |
55. | Avant Immunotherapeutics (1 study) |
56. | AVAX Technologies (1 study) |
57. | Aventis Pharmaceuticals (24 studies) |
58. | AVI BioPharma (1 study) |
59. | The Avicena Group (1 study) |
60. | Avigen (1 study) |
61. | Aviron (1 study) |
62. | Baker Norton Pharmaceuticals (1 study) |
63. | Barr Laboratories (1 study) |
64. | Bausch & Lomb Pharmaceuticals (2 studies) |
65. | Bayer Corporation (11 studies) |
66. | Berlex Laboratories (5 studies) |
67. | Biocine (7 studies) |
68. | Biocodex (1 study) |
69. | BioCryst Pharmaceuticals (6 studies) |
70. | BioCure Medical (1 study) |
71. | Biogen Idec (18 studies) |
72. | Bioheart, Inc. (2 studies) |
73. | BioMarin Pharmaceutical (3 studies) |
74. | Biomeasure Inc, Ipsen Group (2 studies) |
75. | BioMedicines (2 studies) |
76. | Biomira Inc. (2 studies) |
77. | BioNumerik Pharmaceuticals, Inc. (3 studies) |
78. | Biovest International (1 study) |
79. | Boehringer Ingelheim Pharmaceuticals (24 studies) |
80. | Boehringer Mannheim (1 study) |
81. | Boston Scientific Corporation (1 study) |
82. | Bristol-Myers Squibb (117 studies) |
83. | Britannia (1 study) |
84. | British Biotech Pharmaceuticals (2 studies) |
85. | Burroughs Wellcome (1 study) |
86. | BZL Biologics (1 study) |
87. | Callisto Pharmaceuticals (1 study) |
88. | CancerVax Corporation (2 studies) |
89. | Cardio Vascular Genetic Engineering (1 study) |
90. | Cardiome Pharma (1 study) |
91. | Cardiovascular Clinical Research (1 study) |
92. | Celgene Corporation (36 studies) |
93. | Cell Genesys (2 studies) |
94. | Cell Pathways (7 studies) |
95. | Cell Therapeutics (9 studies) |
96. | Cellegy Pharmaceuticals (1 study) |
97. | Celsion (3 studies) |
98. | Centaur Pharmaceuticals (2 studies) |
99. | Centocor (13 studies) |
100. | Cephalon (9 studies) |
101. | Ceregene (1 study) |
102. | ChemGenex Therapeutics (1 study) |
103. | Chimeric Therapies (1 study) |
104. | Chiron Corporation (12 studies) |
105. | Chugai Pharma USA (3 studies) |
106. | Clinical Solutions (1 study) |
107. | Cochlear (1 study) |
108. | Coley Pharmaceutical Group (7 studies) |
109. | Colgate Palmolive (1 study) |
110. | CollaGenex Pharmaceuticals (1 study) |
111. | Columbia Laboratories (1 study) |
112. | Columbia Research Laboratories (1 study) |
113. | Connaught Laboratories (1 study) |
114. | Consultants in Neurology (2 studies) |
115. | Control Delivery Systems (2 studies) |
116. | Copharos (2 studies) |
117. | Corautus Genetics (1 study) |
118. | Corgentech (3 studies) |
119. | Corixa Corporation (10 studies) |
120. | Cortex Pharmaceuticals (2 studies) |
121. | Cosmo Bioscience (1 study) |
122. | CoTherix (1 study) |
123. | CTL ImmunoTherapies Corporation (2 studies) |
124. | Cubist Pharmaceuticals (2 studies) |
125. | Curis (1 study) |
126. | CV Therapeutics (1 study) |
127. | Cytokine PharmaSciences (1 study) |
128. | Cytran (2 studies) |
129. | CytRx (1 study) |
130. | Daiichi Pharmaceuticals (25 studies) |
131. | DEKK-TEC (1 study) |
132. | Dendreon (2 studies) |
133. | DeveloGen Israel, Ltd. (1 study) |
134. | Diagnostic Ultrasound (1 study) |
135. | Direct Therapeutics (2 studies) |
136. | Discovery Laboratories (1 study) |
137. | Dupont Merck (4 studies) |
138. | Dupont Pharmaceuticals (5 studies) |
139. | DynPort Vaccine Company (2 studies) |
140. | EDAP Technomed (1 study) |
141. | Eisai Medical Research Inc (9 studies) |
142. | Elan Pharmaceuticals (16 studies) |
143. | Eleos, Inc. (1 study) |
144. | Eli Lilly and Company (90 studies) |
145. | EMD Pharmaceuticals (1 study) |
146. | Encysive Pharmaceuticals (2 studies) |
147. | Endocyte (1 study) |
148. | Endovasc (1 study) |
149. | EntreMed (1 study) |
150. | Enzon (3 studies) |
151. | Epeius Biotechnologies (1 study) |
152. | Epimmune (2 studies) |
153. | Eunoe (1 study) |
154. | Exelixis (2 studies) |
155. | Eximias Pharmaceutical (1 study) |
156. | Eyetech Pharmaceuticals (5 studies) |
157. | Fallon Clinic (1 study) |
158. | Favrille (3 studies) |
159. | FeRx (3 studies) |
160. | FibroGen (1 study) |
161. | Fisons (5 studies) |
162. | Focus Surgery (2 studies) |
163. | Forest Laboratories (1 study) |
164. | Free Radical Sciences (1 study) |
165. | Fujisawa GmbH (2 studies) |
166. | Fujisawa Healthcare, Inc. (11 studies) |
167. | Fujisawa Pharmaceutical (5 studies) |
168. | G D Searle (4 studies) |
169. | GEIGY Pharmaceuticals (1 study) |
170. | Gem Pharmaceuticals (1 study) |
171. | Genaera (1 study) |
172. | Genelabs Technologies (4 studies) |
173. | Genentech (45 studies) |
174. | Genetics Institute (1 study) |
175. | Genitope (2 studies) |
176. | Genmab (6 studies) |
177. | Genta (9 studies) |
178. | GenVec (2 studies) |
179. | Genzyme (19 studies) |
180. | Genzyme Drug Discovery and Development (1 study) |
181. | GERCOR (22 studies) |
182. | Gilead Sciences (32 studies) |
183. | Glaxo Wellcome (120 studies) |
184. | GlaxoSmithKline (85 studies) |
185. | GMP Endotherapeutics (1 study) |
186. | GPC Biotech (2 studies) |
187. | GTC Biotherapeutics (1 study) |
188. | GTx (1 study) |
189. | Guilford Pharmaceuticals (1 study) |
190. | H. Lundbeck A/S (1 study) |
191. | Health Decisions (1 study) |
192. | HEM Research (1 study) |
193. | Hemispherx Biopharma (2 studies) |
194. | Hemosol (1 study) |
195. | Hepasense (1 study) |
196. | Hoechst Marion Roussel (7 studies) |
197. | Hoffmann-La Roche (108 studies) |
198. | Hollis-Eden Pharmaceuticals (1 study) |
199. | Hudson Health Sciences (1 study) |
200. | Human Genome Sciences (3 studies) |
201. | Icagen (1 study) |
202. | Ichor Medical Systems Incorporated (1 study) |
203. | ICN Pharmaceuticals (2 studies) |
204. | ICON Clinical Research (1 study) |
205. | ICOS (4 studies) |
206. | ICOS-Texas Biotechnology (1 study) |
207. | Idenix Pharmaceuticals (2 studies) |
208. | Idun Pharmaceuticals (2 studies) |
209. | ILEX Oncology (12 studies) |
210. | ILEX Pharmaceuticals (6 studies) |
211. | ILEX Products (10 studies) |
212. | ImClone Systems (11 studies) |
213. | Immune Response (4 studies) |
214. | Immunex Corporation (9 studies) |
215. | Immuno-US (5 studies) |
216. | Immunobiology Research Institute (7 studies) |
217. | Immunomedics, Inc. (8 studies) |
218. | Implant Innovations (1 study) |
219. | Incara Pharmaceuticals (1 study) |
220. | Inex Pharmaceuticals (1 study) |
221. | Inflexxion (2 studies) |
222. | INO Therapeutics (6 studies) |
223. | InSightec-TxSonics (1 study) |
224. | Inspire Pharmaceuticals (4 studies) |
225. | The Institute for Diabetes Discovery, LLC (1 study) |
226. | Integrated Therapeutics Group (1 study) |
227. | Interferon Sciences (2 studies) |
228. | InterMune (18 studies) |
229. | Intracel (2 studies) |
230. | Introgen Therapeutics (5 studies) |
231. | Isis Pharmaceuticals (12 studies) |
232. | IVAX Research (9 studies) |
233. | Jacobus Pharmaceutical (6 studies) |
234. | Janssen Pharmaceutica (18 studies) |
235. | Johnson & Johnson Pharmaceutical Research and Development, L.L.C. (41 studies) |
236. | KAI Pharmaceuticals (1 study) |
237. | Kanglaite-USA (1 study) |
238. | King Pharmaceuticals (1 study) |
239. | Kos Pharmaceuticals (5 studies) |
240. | Kosan Biosciences (2 studies) |
241. | KS Biomedix (1 study) |
242. | La Jolla Pharmaceutical Company (2 studies) |
243. | Leap of Faith Technologies (1 study) |
244. | Lederle Laboratories (7 studies) |
245. | Lederle-Praxis Biologicals (2 studies) |
246. | LEO Pharma (2 studies) |
247. | Lexigen Pharmaceuticals (1 study) |
248. | LifeCell (1 study) |
249. | LifeTime Pharmaceuticals (3 studies) |
250. | Ligand Pharmaceuticals (12 studies) |
251. | Light Sciences Corporation (3 studies) |
252. | Liposome (1 study) |
253. | Lorus Therapeutics (3 studies) |
254. | Luitpold Pharmaceuticals (1 study) |
255. | LXR Biotechnology (1 study) |
256. | LyphoMed (2 studies) |
257. | Matrix Pharmaceutical (3 studies) |
258. | Maxim Pharmaceuticals (2 studies) |
259. | McNeil Consumer & Specialty Pharmaceuticals (2 studies) |
260. | Medarex (3 studies) |
261. | Medical Research Laboratories International (3 studies) |
262. | The Medicines Company (13 studies) |
263. | MediGene (1 study) |
264. | MedImmune, Inc. (5 studies) |
265. | Medsearch (1 study) |
266. | Medstone International (1 study) |
267. | Medtronic (1 study) |
268. | Merck (113 studies) |
269. | Merck KGaA (3 studies) |
270. | Merck Research Laboratories (17 studies) |
271. | Merieux Institute (1 study) |
272. | Merix (1 study) |
273. | Metabasis Therapeutics (1 study) |
274. | MetaPhore Pharmaceuticals (1 study) |
275. | Meyer Pharmaceuticals (1 study) |
276. | MGI Pharma (1 study) |
277. | MicroGeneSys (6 studies) |
278. | Micrologix Biotech (1 study) |
279. | Miles (1 study) |
280. | Milkhaus Laboratory (1 study) |
281. | Millennium Pharmaceuticals (19 studies) |
282. | Millennix (1 study) |
283. | Mitsubishi Pharma Corporation (3 studies) |
284. | Mucos Pharma GmbH and Co (1 study) |
285. | Mylan Laboratories (1 study) |
286. | Myogen (4 studies) |
287. | Myriad Pharmaceuticals (1 study) |
288. | Nabi Biopharmaceuticals (3 studies) |
289. | Neopharm (13 studies) |
290. | NeoRx Corporation (3 studies) |
291. | NeoTherapeutics (1 study) |
292. | Neurex (1 study) |
293. | Neurobiological Technologies (2 studies) |
294. | Neurochem Inc. (3 studies) |
295. | Neurocrine Biosciences (3 studies) |
296. | NeurogesX (8 studies) |
297. | NeuroPace (1 study) |
298. | NewBiotics (1 study) |
299. | NewLink Genetics Corporation (1 study) |
300. | Newport Pharmaceuticals International (6 studies) |
301. | Nexstar Pharmaceuticals (1 study) |
302. | Nitromed (1 study) |
303. | Nobel Biocare (1 study) |
304. | North American Biologicals Inc (1 study) |
305. | Northfield Laboratories (1 study) |
306. | Northwest Biotherapeutics (2 studies) |
307. | Novacea (5 studies) |
308. | Novartis Pharmaceuticals (54 studies) |
309. | Novo Nordisk Pharmaceuticals (3 studies) |
310. | Novogen (1 study) |
311. | Novum (1 study) |
312. | Novuspharma (2 studies) |
313. | NPS Allelix Corp. (2 studies) |
314. | NS Pharma, Inc. (1 study) |
315. | Nucryst Pharmaceuticals (1 study) |
316. | Nuvelo (2 studies) |
317. | Oakwood Laboratories, LLC (1 study) |
318. | Oclassen Pharmaceuticals (2 studies) |
319. | Oculex Pharmaceuticals (1 study) |
320. | Oncotech (1 study) |
321. | Oncotherapeutics (1 study) |
322. | Ono Pharma (2 studies) |
323. | Onyvax (1 study) |
324. | ONYX Pharmaceuticals (2 studies) |
325. | Organon (6 studies) |
326. | ORION Clinical Services (1 study) |
327. | Orphan Medical (5 studies) |
328. | Orphan Therapeutics (1 study) |
329. | Ortho Biotech (1 study) |
330. | Ortho Dermatologics (1 study) |
331. | Ortho Pharmaceuticals (6 studies) |
332. | Ortho-McNeil Pharmaceutical (1 study) |
333. | OSI Pharmaceuticals (15 studies) |
334. | Otsuka America Pharmaceutical (6 studies) |
335. | Otsuka Maryland Research Institute (7 studies) |
336. | Oxford BioMedica (1 study) |
337. | OXO Chemie (1 study) |
338. | Oxo Chemie GmbH (2 studies) |
339. | Pan American Laboratories (1 study) |
340. | Parexel (1 study) |
341. | Parke-Davis (5 studies) |
342. | Pasteur Merieux Connaught (1 study) |
343. | Peptimmune (1 study) |
344. | Peregrine Pharmaceuticals (1 study) |
345. | Pfizer (112 studies) |
346. | Pharmacia (9 studies) |
347. | Pharmacia and Upjohn (13 studies) |
348. | Pharmacyclics (7 studies) |
349. | PharmaMar (5 studies) |
350. | PharmaNet (2 studies) |
351. | PharmaResearch (1 study) |
352. | Pharmasset (2 studies) |
353. | Pharmatech Oncology (4 studies) |
354. | Pharmion (1 study) |
355. | PhytoCeutica (2 studies) |
356. | Point Therapeutics (4 studies) |
357. | PPD (1 study) |
358. | Pro Vantage (1 study) |
359. | Pro-Pharmaceuticals (1 study) |
360. | Procept (1 study) |
361. | Procter & Gamble Pharmaceuticals (13 studies) |
362. | Progen Industries Limited (2 studies) |
363. | Progenics Pharmaceuticals (1 study) |
364. | Prologue Research International (3 studies) |
365. | Proneuron Biotechnologies (1 study) |
366. | Protein Design Labs (13 studies) |
367. | Purdue Frederick (1 study) |
368. | QLT Inc (6 studies) |
369. | Quintiles (4 studies) |
370. | R W Johnson Pharmaceutical Research Institute (2 studies) |
371. | Repligen Corporation (3 studies) |
372. | Rhone-Poulenc Rorer (3 studies) |
373. | Ribapharm (1 study) |
374. | RIBI Immunochem Research (1 study) |
375. | Ribozyome (1 study) |
376. | RITA Medical Systems (1 study) |
377. | Roberts Pharmaceutical (1 study) |
378. | Romark Laboratories L.C. (2 studies) |
379. | Roxane Laboratories (2 studies) |
380. | Saegis Pharmaceuticals (1 study) |
381. | Salmedix (2 studies) |
382. | Sandoz Pharmaceuticals (10 studies) |
383. | Sangstat Medical Corporation (3 studies) |
384. | Sanofi-Synthelabo (16 studies) |
385. | Santarus (1 study) |
386. | Sarawak MediChem Pharmaceuticals (2 studies) |
387. | Savient Pharmaceuticals (1 study) |
388. | Schering-Plough (33 studies) |
389. | SciClone Pharmaceuticals (4 studies) |
390. | Scios (6 studies) |
391. | Seattle Genetics (9 studies) |
392. | Selective Genetics (1 study) |
393. | Sepracor, Inc. (6 studies) |
394. | Sequus Pharmaceuticals (5 studies) |
395. | Serono (4 studies) |
396. | Shaman Pharmaceuticals (3 studies) |
397. | Shionogi (2 studies) |
398. | Shire Pharmaceutical Development (3 studies) |
399. | Sigma-Tau Research, Inc. (3 studies) |
400. | Simbec Research (1 study) |
401. | Sirius Medicine (1 study) |
402. | SkyePharma (2 studies) |
403. | SmithKline Beecham (6 studies) |
404. | Somerset Pharmaceuticals (1 study) |
405. | Sonus Pharmaceuticals (5 studies) |
406. | Spectrum Pharmaceuticals, Inc (1 study) |
407. | Speedel Bio (1 study) |
408. | Stolle Milk Biologic International (1 study) |
409. | Stressgen Biotechnologies (1 study) |
410. | SUGEN (8 studies) |
411. | Sumitomo Pharmaceuticals America (4 studies) |
412. | Sunesis Pharmaceuticals (2 studies) |
413. | Suntory Pharmaceutical (2 studies) |
414. | SuperGen (16 studies) |
415. | Symphony Neuro Development Company (1 study) |
416. | Synta Pharmaceuticals, Corp. (6 studies) |
417. | Systemix (1 study) |
418. | Taiho Pharma USA, Inc. (1 study) |
419. | Takeda Pharmaceuticals (2 studies) |
420. | Tanox (1 study) |
421. | TAP Pharmaceutical Products (1 study) |
422. | Targeted Genetics Coporation (1 study) |
423. | Telik (11 studies) |
424. | Texas Biotechnology Corporation (2 studies) |
425. | Theradex (15 studies) |
426. | Therakos (3 studies) |
427. | Theravance (4 studies) |
428. | Tibotec Pharmaceutical (3 studies) |
429. | Tillotts Pharma AG (1 study) |
430. | Titan Pharmaceuticals (5 studies) |
431. | Transgene (1 study) |
432. | Transkaryotic Therapies (1 study) |
433. | TransMolecular (1 study) |
434. | Triangle Pharmaceuticals (10 studies) |
435. | Trimeris (7 studies) |
436. | Tularik (7 studies) |
437. | U.S. Bioscience (5 studies) |
438. | Unimed Pharmaceuticals (1 study) |
439. | United Biomedical (3 studies) |
440. | United Therapeutics (7 studies) |
441. | Unither Pharmaceuticals (2 studies) |
442. | Univax Biologics Inc (1 study) |
443. | Upjohn (7 studies) |
444. | Urologix (1 study) |
445. | Valentis (1 study) |
446. | Vascular Sciences Corporation (1 study) |
447. | VaxGen (3 studies) |
448. | Versicor (1 study) |
449. | Vertex Pharmaceuticals (2 studies) |
450. | ViaCell (1 study) |
451. | Vical (4 studies) |
452. | Vicuron Pharmaceuticals (5 studies) |
453. | VIMRx Pharmaceuticals (2 studies) |
454. | Vion Pharmaceuticals (15 studies) |
455. | ViRx (1 study) |
456. | VitaGen (1 study) |
457. | Voyager Pharmaceutical Corporation (2 studies) |
458. | Warner Lambert - Parke Davis (1 study) |
459. | WellSpring Pharmaceutical Corporation (1 study) |
460. | Wellstat Therapeutics (2 studies) |
461. | Wilex (2 studies) |
462. | Winston Laboratories (3 studies) |
463. | Wyeth-Ayerst Research (56 studies) |
464. | Wyeth-Lederle Vaccines (2 studies) |
465. | Xanthus Life Sciences (1 study) |
466. | Xcyte Therapies (4 studies) |
467. | Xenova Biomedix (2 studies) |
468. | XOMA (3 studies) |
469. | Yamanouchi Pharma America (5 studies) |
470. | Zivena (1 study) |
471. | ZymoGenetics (1 study) |
472. | �ngstrom Pharmaceuticals (1 study) |